Norris Medicines Limited's Board approved the quarterly financial results.

The Board also appointed Mr. Vimal Dhirendra Shah as Managing Director for three years, effective September 1, 2026. This appointment, which requires shareholder approval, brings an experienced leader with over 15 years in business management to the helm.

Mr. Shah's background includes overseeing business operations and contributing to company growth, making this a significant leadership update for stakeholders.